We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
20 hedge funds and large institutions have $52.2M invested in Arcturus Therapeutics in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
82% more funds holding
Funds holding: 11 → 20 (+9)
65% more capital invested
Capital invested by funds: $31.6M → $52.2M (+$20.6M)
Holders
20
Holders Change
+9
Holders Change %
+81.82%
% of All Funds
0.58%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
10
Increased
7
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$5.39M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.49M |
| 3 |
SC
Sophrosyne Capital
New York
|
+$3.67M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.27M |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.8M |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$36.7K |
| 2 |
PCM
Prelude Capital Management
New York
|
-$25K |
| 3 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$18K |
